Functional Analysis of the Chemokine Receptor CCR3 on Airway Epithelial CellsLisa A. Beck, Cristiana Stellato, Martyn Foster et al.|The Journal of Immunology|2006Cited by 53
Abstract GS3-10: Study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in combination with fulvestrant in patients with advanced hormone receptor positive HER2 negative breast cancer (HR+BC)R. Charles Coombes, Stuart McIntosh, Sacha J. Howell et al.|Cancer Research|2022Cited by 7
Abstract P1-18-10: A clinical study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in patients with advanced triple negative breast cancer (TNBC)Sacha J. Howell, R. Charles Coombes, Laura Kenny et al.|Cancer Research|2022Cited by 5